Actively Recruiting
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
Led by Hackensack Meridian Health · Updated on 2025-10-24
127
Participants Needed
1
Research Sites
412 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Inability to urinate a common complication that happens to many patients after a surgery, especially in men over 60 years of age who undergo surgery on their chest. Urinary retention is uncomfortable, increases anxiety, increases hospital length of stay, and leads to more procedures such as putting in a bladder catheter (Foley). This is uncomfortable, and can lead to bleeding, infection, damage to the urethra and/or bladder and bladder spasm. The goal of this study is to attempt to prevent inability to urinate by giving patients a medication called Flomax (Tamusolin) every day beginning a week before surgery. That medication relaxes the prostate. It's approved by the Food and Drug Administration (FDA) to improve urinary flow in those with enlarged prostates. It is also commonly used in patients with bladder problems due to inability to urinate who have required a Foley.
CONDITIONS
Official Title
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male
- Age 50 years or older
- Planned minimally invasive thoracic surgery (wedge resection, segmentectomy, lobectomy, pleural biopsy, or pleurodesis)
- Surgery scheduled at least 3 days after consent
You will not qualify if you...
- Currently using Flomax
- Allergy to Flomax or sulfa drugs
- Current use of alpha blockers or alpha agonists
- Resting systolic blood pressure less than 100 mm Hg
- Orthostatic hypotension over 20 mm Hg systolic or 10 mm Hg diastolic after standing for 2 minutes
- Known congestive heart failure or valvular heart disease
- History of prostate surgery such as prostatectomy or trans-urethral resection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Daniel Mansour
Hackensack, New Jersey, United States, 07601
Actively Recruiting
Research Team
D
Daniel Mansour, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here